Cargando…

Epidemiology and (Patho)Physiology of Folic Acid Supplement Use in Obese Women before and during Pregnancy

Preconception folic acid supplement use is a well-known method of primary prevention of neural tube defects (NTDs). Obese women are at a higher risk for having a child with a NTD. As different international recommendations on folic acid supplement use for obese women before and during pregnancy exis...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Windt, Melissa, Schoenmakers, Sam, van Rijn, Bas, Galjaard, Sander, Steegers-Theunissen, Régine, van Rossem, Lenie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911986/
https://www.ncbi.nlm.nih.gov/pubmed/33498674
http://dx.doi.org/10.3390/nu13020331
_version_ 1783656470833790976
author van der Windt, Melissa
Schoenmakers, Sam
van Rijn, Bas
Galjaard, Sander
Steegers-Theunissen, Régine
van Rossem, Lenie
author_facet van der Windt, Melissa
Schoenmakers, Sam
van Rijn, Bas
Galjaard, Sander
Steegers-Theunissen, Régine
van Rossem, Lenie
author_sort van der Windt, Melissa
collection PubMed
description Preconception folic acid supplement use is a well-known method of primary prevention of neural tube defects (NTDs). Obese women are at a higher risk for having a child with a NTD. As different international recommendations on folic acid supplement use for obese women before and during pregnancy exist, this narrative review provides an overview of epidemiology of folate deficiency in obese (pre)pregnant women, elaborates on potential mechanisms underlying folate deficiency, and discusses considerations for the usage of higher doses of folic acid supplements. Women with obesity more often suffer from an absolute folate deficiency, as they are less compliant to periconceptional folic acid supplement use recommendations. In addition, their dietary folate intake is limited due to an unbalanced diet (relative malnutrition). The association of obesity and NTDs also seems to be independent of folate intake, with studies suggesting an increased need of folate (relative deficiency) due to derangements involved in other pathways. The relative folate deficiency, as a result of an increased metabolic need for folate in obese women, can be due to: (1) low-grade chronic inflammation (2) insulin resistance, (3) inositol, and (4) dysbiotic gut microbiome, which plays a role in folate production and uptake. In all these pathways, the folate-dependent one-carbon metabolism is involved. In conclusion, scientific evidence of the involvement of several folate-related pathways implies to increase the recommended folic acid supplementation in obese women. However, the physiological uptake of synthetic folic acid is limited and side-effects of unmetabolized folic acid in mothers and offspring, in particular variations in epigenetic (re)programming with long-term health effects, cannot be excluded. Therefore, we emphasize on the urgent need for further research and preconception personalized counseling on folate status, lifestyle, and medical conditions.
format Online
Article
Text
id pubmed-7911986
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-79119862021-02-28 Epidemiology and (Patho)Physiology of Folic Acid Supplement Use in Obese Women before and during Pregnancy van der Windt, Melissa Schoenmakers, Sam van Rijn, Bas Galjaard, Sander Steegers-Theunissen, Régine van Rossem, Lenie Nutrients Review Preconception folic acid supplement use is a well-known method of primary prevention of neural tube defects (NTDs). Obese women are at a higher risk for having a child with a NTD. As different international recommendations on folic acid supplement use for obese women before and during pregnancy exist, this narrative review provides an overview of epidemiology of folate deficiency in obese (pre)pregnant women, elaborates on potential mechanisms underlying folate deficiency, and discusses considerations for the usage of higher doses of folic acid supplements. Women with obesity more often suffer from an absolute folate deficiency, as they are less compliant to periconceptional folic acid supplement use recommendations. In addition, their dietary folate intake is limited due to an unbalanced diet (relative malnutrition). The association of obesity and NTDs also seems to be independent of folate intake, with studies suggesting an increased need of folate (relative deficiency) due to derangements involved in other pathways. The relative folate deficiency, as a result of an increased metabolic need for folate in obese women, can be due to: (1) low-grade chronic inflammation (2) insulin resistance, (3) inositol, and (4) dysbiotic gut microbiome, which plays a role in folate production and uptake. In all these pathways, the folate-dependent one-carbon metabolism is involved. In conclusion, scientific evidence of the involvement of several folate-related pathways implies to increase the recommended folic acid supplementation in obese women. However, the physiological uptake of synthetic folic acid is limited and side-effects of unmetabolized folic acid in mothers and offspring, in particular variations in epigenetic (re)programming with long-term health effects, cannot be excluded. Therefore, we emphasize on the urgent need for further research and preconception personalized counseling on folate status, lifestyle, and medical conditions. MDPI 2021-01-23 /pmc/articles/PMC7911986/ /pubmed/33498674 http://dx.doi.org/10.3390/nu13020331 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
van der Windt, Melissa
Schoenmakers, Sam
van Rijn, Bas
Galjaard, Sander
Steegers-Theunissen, Régine
van Rossem, Lenie
Epidemiology and (Patho)Physiology of Folic Acid Supplement Use in Obese Women before and during Pregnancy
title Epidemiology and (Patho)Physiology of Folic Acid Supplement Use in Obese Women before and during Pregnancy
title_full Epidemiology and (Patho)Physiology of Folic Acid Supplement Use in Obese Women before and during Pregnancy
title_fullStr Epidemiology and (Patho)Physiology of Folic Acid Supplement Use in Obese Women before and during Pregnancy
title_full_unstemmed Epidemiology and (Patho)Physiology of Folic Acid Supplement Use in Obese Women before and during Pregnancy
title_short Epidemiology and (Patho)Physiology of Folic Acid Supplement Use in Obese Women before and during Pregnancy
title_sort epidemiology and (patho)physiology of folic acid supplement use in obese women before and during pregnancy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911986/
https://www.ncbi.nlm.nih.gov/pubmed/33498674
http://dx.doi.org/10.3390/nu13020331
work_keys_str_mv AT vanderwindtmelissa epidemiologyandpathophysiologyoffolicacidsupplementuseinobesewomenbeforeandduringpregnancy
AT schoenmakerssam epidemiologyandpathophysiologyoffolicacidsupplementuseinobesewomenbeforeandduringpregnancy
AT vanrijnbas epidemiologyandpathophysiologyoffolicacidsupplementuseinobesewomenbeforeandduringpregnancy
AT galjaardsander epidemiologyandpathophysiologyoffolicacidsupplementuseinobesewomenbeforeandduringpregnancy
AT steegerstheunissenregine epidemiologyandpathophysiologyoffolicacidsupplementuseinobesewomenbeforeandduringpregnancy
AT vanrossemlenie epidemiologyandpathophysiologyoffolicacidsupplementuseinobesewomenbeforeandduringpregnancy